Published in Biomed Res Int on May 05, 2014
Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol (2004) 3.76
GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol (2005) 2.55
Site-specific acetylation by p300 or CREB binding protein regulates erythroid Krüppel-like factor transcriptional activity via its interaction with the SWI-SNF complex. Mol Cell Biol (2001) 1.93
Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol (2006) 1.58
Hypoxia alters progression of the erythroid program. Exp Hematol (2007) 1.04
Levels of GATA-1/GATA-2 transcription factors modulate expression of embryonic and fetal hemoglobins. Gene (2000) 1.02
Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood (2004) 1.00
In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion (2008) 0.98
Red blood cells from induced pluripotent stem cells: hurdles and developments. Curr Opin Hematol (2011) 0.98
Comparison of Sebia Capillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies. Am J Clin Pathol (2008) 0.96
Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer. Transfusion (2009) 0.88
Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion. Int J Hematol (2012) 0.87
Red blood cell engineering in stroma and serum/plasma-free conditions and long term storage. Tissue Eng Part A (2011) 0.85
The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production. J Biotechnol (2009) 0.85
Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo. Exp Hematol (2009) 0.84
In-vitro stem cell derived red blood cells for transfusion: are we there yet? Yonsei Med J (2014) 0.82
Best practices for use of the HEMOX analyzer in the clinical laboratory: quality control determination and choice of anticoagulant. Lab Hematol (2012) 0.79